Clinical Application of Molecular Features in Therapeutic Selection and Drug Development

The previous chapter (“Validation of Genomic-Based Assay”) introduced general methodologies on biomarkers evaluation for clinical utility and analytical validity, with an illustrating example of BRAF V600E for both aspects. In this chapter, we focus on a specific type of biomarkers: the ones useful for therapeutic decision and therapeutic drug development in the clinical setting.